In a more recent clinical trial, 42 patients with stage II-IV esophageal cancer received treatment with low-dose neoadjuvant chemotherapy combined with radiation therapy.. Overall, 51% of patients were alive 2 years after treatment and 91% of the patients achieving a complete response to treatment survived.
In one clinical trial, stage II esophageal cancer patients who received combined chemotherapy and radiation therapy experienced a 5-year survival rate of 20% with local cancer recurrences occurring in 45% of patients.
Stage II esophageal cancer. A stage II esophageal cancer tumor has grown larger but still remains within the esophagus. In this stage of the disease, there is no evidence of spread to lymph nodes or distant sites (Example: T2, N0, M0).
Esophageal cancer is an aggressive form of cancer, and one that often. . Most patients with localized esophageal cancer (stage 1 or 2 disease) used to be .
You will also read general information on surviving the disease.. The disease accounts for 1% of cancers diagnosed in the United States.. However, survival rates depend on several factors, including the stage of the cancer when it is. Type 2, Nevoid Basal Cell Carcinoma Syndrome, Oral and Oropharyngeal Cancer .
Up to date, surgical resection is the main treatment of esophageal cancer. This study was to analyze the correlations of clinicopathologic features of stage II .